NCT05494177

Brief Summary

Primary objective of this study is to compare two presbyopia correction surgical techniques, specificaly premium monovision, in which the dominant eye is corrected with an extended depth of field intraocular lens and the non-dominant eye with a trifocal diffractive intraocular lens, and the bilateral implantation of trifocal diffractive intraocular lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

August 6, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 9, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

June 18, 2023

Status Verified

August 1, 2022

Enrollment Period

4 months

First QC Date

August 6, 2022

Last Update Submit

June 15, 2023

Conditions

Keywords

pseudophakic presbyopic correctionpremium monovisiontrifocal diffractive intraocular lensesextended depth of field intraocular lenses

Outcome Measures

Primary Outcomes (5)

  • Binocular uncorrected distant visual acuity (bUDVA)

    bUDVA is obtained using the distance vision test of DDART at four meters distance.

    1 year

  • Binocular uncorrected intermediate reading acuity (bUIRA)

    bUIRA is obtained using the near vision test of DDART at 60 cm distance.

    1 year

  • Binocular uncorrected near reading acuity (bUNRA)

    bUNRA is obtained using the near vision test of DDART at 40 cm distance.

    1 year

  • Binocular uncorrected intermediate critical print size (bUICPS)

    bUICPS is obtained using the near vision test of DDART at 60 cm distance.

    1 year

  • Binocular uncorrected near critical print size (bUNCPS)

    bUNCPS is obtained using the near vision test of DDART at 40 cm distance.

    1 year

Secondary Outcomes (4)

  • Dysphotopsia symptoms

    1 year

  • Contrast sensitivity

    1 year

  • Spectacle independence

    1 year

  • Subjective satisfaction using Visual Function Index (VF-14) (total score, VF14-Near Vision (NV) score & VF14-Distance Vision (DV) score)

    1 year

Study Arms (2)

Premium monovision

Patients will undergo to implantation of an extended depth of field intraocular lens in the dominant eye and a trifocal diffractive intraocular lens in the non-dominant eye.

Diagnostic Test: bUDVA, bUIRA, bUNRA, bUICPS, bUNCPSDiagnostic Test: Contrast sensitivity

Bilateral trifocal diffractive implantation

Patients will undergo to bilateral implantation of trifocal diffractive lenses.

Diagnostic Test: bUDVA, bUIRA, bUNRA, bUICPS, bUNCPSDiagnostic Test: Contrast sensitivity

Interventions

All participants will be assessed on the following clinical indexes: 1. Binocular uncorrected distant visual acuity (bUDVA) at four meters distance 2. Binocular uncorrected intermediate reading acuity (bUIRA) at 60 cm 3. Binocular uncorrected near reading acuity (bUNVA) at 40 cm 4. Binocular uncorrected intermediate Critical Print Size (bUICPS) at 60 cm 5. Binocular uncorrected near Critical Print Size (bUNCPS) at 40 cm All the above parameters are obtained using the Democritus Digital Acuity \& Reading Test (DDART).

Bilateral trifocal diffractive implantationPremium monovision
Contrast sensitivityDIAGNOSTIC_TEST

Contrast sensitivity is assessed with the Pelli-Robson test.

Bilateral trifocal diffractive implantationPremium monovision

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who were examined at the outpatient of the Department of Ophthalmology of the University General Hospital of Alexandroupolis with the diagnosis of cataract with stage 2 (according to LOCS III) and underwent one of the following presbyopia correction surguries: 1. Bilateral implantation of trifocal diffractive intraocular lenses 2. Premium monovision with implantation of an extended depth of focus intraocular lens in the dominant eye and a trifocal diffractive intraocular lens in the non-dominant eye

You may qualify if:

  • Diagnosis of cataract with stage 2 according to the Lens Opacities Classification System III (LOCS-3) grading scale
  • Age\>45 years

You may not qualify if:

  • Disability to understand the Greek language and respond to the interview
  • Fundus or corneal diseases
  • Glaucoma
  • Previous intraocular surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ophthalmology, University Hospital of Alexandroupolis

Alexandroupoli, Evros, 68100, Greece

Location

Related Publications (1)

  • Labiris G, Panagis C, Ntonti P, Konstantinidis A, Bakirtzis M. Mix-and-match vs bilateral trifocal and bilateral EDOF intraocular lens implantation: the spline curve battle. J Cataract Refract Surg. 2024 Feb 1;50(2):167-173. doi: 10.1097/j.jcrs.0000000000001336.

MeSH Terms

Conditions

PresbyopiaRefractive ErrorsCataract

Interventions

Contrast Sensitivity

Condition Hierarchy (Ancestors)

Eye DiseasesLens Diseases

Intervention Hierarchy (Ancestors)

Visual AcuityVision TestsDiagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosisOcular Physiological Phenomena

Study Officials

  • Georgios Labiris, MD, PhD

    Department of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor (Associate) of Democritus University of Thrace

Study Record Dates

First Submitted

August 6, 2022

First Posted

August 9, 2022

Study Start

August 1, 2022

Primary Completion

December 1, 2022

Study Completion

March 1, 2023

Last Updated

June 18, 2023

Record last verified: 2022-08

Locations